#ITI#Vaccine Protection of Turkeys Against H5N1 Highly Pathogenic Avian Influenza Virus with a Recombinant Turkey Herpesvirus Expressing the Hemagglutinin Gene of Avian Influenza#FTI#
#IRE#Outbreaks of H5 highly pathogenic avian influenza (HPAI) in commercial poultry are a constant threat to animal health and food supplies. While vaccination can enhance protection and reduce the spread of disease, there is considerable evidence that the level of immunity required for protection varies by subtype and virulence of field virus. In this study, the efficacy of a recombinant Turkey herpesvirus (rHVT) vector vaccine expressing the hemagglutinin gene from a clade 2.2 AI virus (A/Swan/Hungary/4999/2006) was evaluated in Turkeys for protection against challenge with A/Whooper Swan/Mongolia/L244/2005 H5N1 HPAI clade 2.2. One-day-old Turkeys received a single vaccination and were challenged at 4 wk postvaccination with 2 Ã— 106 50% embryo infectious dose per bird. The results demonstrate that following H5N1 HPAI challenge 96% protection was observed in rHVT-AI vaccinated Turkeys. The oral and cloacal swabs taken from challenged birds demonstrated that vaccinated birds had lower incidence and titers of viral shedding compared with sham-vaccinated birds. From respiratory and gastrointestinal tracts, there was a greater than 6 log10 reduction in shedding in vaccinated birds as compared with the controls. This study provides support for the use of a commercially available rHVT-AI vaccine to protect Turkeys against H5N1 HPAI.#FRE#
#IPC#H5N1; Highly pathogenic avian influenza virus; HVT-AI vector vaccine; potency; Turkey#FPC#
#IRF#Alexander D.J., A review of avian influenza in different bird species, Vet. Microbiol., 74, pp. 3-13, (2000); 
Alexander D.J., Summary of avian influenza activity in Europe Asia Africa and Australia 2002-2006, Avian Dis., 51, pp. 161-166, (2007); 
Balish A.L., Davis C.T., Saad M.D., El-Sayed N., Esmat H., Tjaden J.A., Earhart K.C., Ahmed L.E., Abd El-Halem M., Ali A.H., Nassif S.A., El-Ebiary E.A., Taha M., Aly M.M., Arafa A., O'Neill E., Xiyan X., Cox N.J., Donis R.O., Klimov A.I., Antigenic and genetic diversity of highly pathogenic avian influenza A (H5N1) viruses isolated in Egypt, Avian Dis., 54, pp. 329-334, (2010); 
Bublot M., Pritchard N., Le Gros F.X., Goutebroze S., Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody, J. Comp. Pathol., 137, pp. 81-84, (2007); 
Escorcia M., Carrillo-Sanchez K., March-Mifsut S., Chapa J., Lucio E., Nava G.M., Impact of antigenic and genetic drift on the serologic surveillance of H5N2 avian influenza viruses, BMC Vet. Res., 6, (2010); 
Escorcia M., Vazquez L., Mendez S.T., Rodriguez-Ropon A., Lucio E., Nava G.M., Avian influenza: Genetic evolution under vaccination pressure, Virol. J., 5, (2008); 
Food and Agriculture Organization of the United Nations. Approaches to Controlling, Preventing and Eliminating H5N1 Highly Pathogenic Avian Influenza in Endemic Countries, (2011); 
Kapczynski D.R., Esaki M., Dorsey K.M., Jiang H., Jackwood M., Moraes M., Gardin Y., Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus, Vaccine, 33, pp. 1197-1205, (2015); 
Kapczynski D.R., Pantin-Jackwood M., Guzman S.G., Ricardez Y., Spackman E., Bertran K., Suarez D.L., Swayne D., Characterization of the 2012 highly pathogenic avian influenza H7N3 virus isolated from poultry in an outbreak in Mexico: Pathobiology and vaccine protection, J Virol., 87, pp. 9086-9096, (2013); 
Kilany W.H., Abdelwhab E.M., Arafa A.S., Selim A., Safwat M., Nawar A.A., Erfan A.M., Hassan M.K., Aly M.M., Hafez H.M., Protective efficacy of H5 inactivated vaccines in meat Turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus, Vet. Microbiol., 150, pp. 28-34, (2011); 
Lee D.H., Torchetti M.K., Winker K., Ip H.S., Song C.S., Swayne D.E., Intercontinental spread of Asian-origin H5N8 to North America through Beringia by migratory birds, J Virol., 89, pp. 6521-6534, (2015); 
Mannelli A., Ferre N., Marangon S., Analysis of the 1999-2000 highly pathogenic avian influenza (H7N1) epidemic in the main poultry-production area in northern Italy, Prev. Vet. Med., 73, pp. 273-285, (2006); 
Morgan R.W., Gelb J.J., Pope C.R., Sondermeijer P.J.A., Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: Onset of protection and effect of maternal antibodies, Avian Dis., 37, pp. 1032-1040, (1993); 
Naeem K., Siddique N., Use of strategic vaccination for the control of avian influenza in Pakistan, Dev. Biol., 124, pp. 145-150, (2006); 
Pasick J., Handel K., Robinson J., Copps J., Ridd D., Hills K., Kehler H., Cottam-Birt C., Neufeld J., Berhane Y., Czub S., Interseg-mental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia, J. Gen. Virol., 86, pp. 727-731, (2005); 
Pedersen J.C., Hemagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to influenza virus, Methods Mol. Biol., 1161, pp. 11-25, (2014); 
Perozo F., Villegas P., Fernandez R., Cruz J., Pritchard N., Efficacy of single dose recombinant herpesvirus of Turkey infectious bursal disease virus (IBDV) vaccination against a variant IBDV strain, Avian Dis., 53, pp. 624-628, (2009); 
Rauw F., Gardin Y., Palya V., Anbari S., Lemaire S., Boschmans M., Van Den Berg T., Lambrecht B., Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old, Vaccine, 28, pp. 823-833, (2010); 
Rauw F., Palya V., Van Borm S., Welby S., Tatar-Kis T., Gardin Y., Dorsey K.M., Aly M.M., Hassan M.K., Soliman M.A., Lambrecht B., Van Den Berg T., Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains, Vaccine, 29, pp. 2590-2600, (2011); 
Rojas H., Moreira R., Avalos P., Capua I., Marangon S., Avian influenza in poultry in Chile, Vet. Rec., 151, (2002); 
Senne D.A., Virus propagation in embryonating eggs, A Laboratory Manual for the Isolation, Identification and Characterization of Avian Pathogens, pp. 204-208, (2008); 
Soejoedono R.D., Murtini S., Palya V., Felfoldi B., Mato T., Gardin Y., Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains, Avian Dis., 56, pp. 923-927, (2012); 
Swayne D.E., Beck J.R., Perdue M.L., Beard C.W., Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza, Avian Dis., 45, pp. 355-365, (2001); 
Swayne D.E., Beck J.R., Perdue M.L., Brugh M., Slemons R.D., Assessment of the ability of ratite-origin influenza viruses to infect and produce disease in rheas and chickens, Avian Dis., 40, pp. 438-447, (1996); 
Swayne D.E., Kapczynski D.R., Strategies and challenges for eliciting immunity against avian influenza virus in birds, Immunol. Rev., 225, pp. 314-331, (2008); 
Swayne D.E., Kapczynski D.R., Vaccines, vaccination and immunology for avian influenza viruses in poultry, Avian Influenza, pp. 407-451, (2008); 
Swayne D.E., Pavade G., Hamilton K., Vallat B., Miyagishima K., Assessment of national strategies for control of high pathogenicity avian influenza and low pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination, Rev. Sci. Tech., 30, pp. 839-870, (2011); 
Swayne D.E., Suarez D., Spackman E., Jadhao S., Dauphin G., Kim-Torchetti M., McGrane J., Weaver J., Daniels P., Wong F., Selleck P., Wiyono A., Indriani R., Yupiana Y., Sawitri Siregar E., Prajitno T., Smith D., Fouchier R., Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia, J Virol., 89, pp. 3746-3762, (2015); 
Toffan A., Serena Beato M., De Nardi R., Bertoli E., Salviato A., Cattoli G., Terregino C., Capua I., Conventional inactivated bivalent H5/H7 vaccine prevents viral localization in muscles of turkeys infected experimentally with low pathogenic avian influenza and highly pathogenic avian influenza H7N1 isolates, Avian Pathol., 37, pp. 407-412, (2008); 
Tsukamoto K., Saito S., Saeki S., Sato T., Tanimura N., Isobe T., Mase M., Imada T., Yuasa N., Yamaguchi S., Complete, long lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens, J Virol., 76, pp. 5637-5645, (2002); 
Tumpey T.M., Garcia-Sastre A., Taubenberger J.K., Palese P., Swayne D.E., Basler C.F., Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus, Proc. Natl. Acad. Sci. U. S. A., 101, pp. 3166-3171, (2004); 
Tumpey T.M., Kapczynski D.R., Swayne D.E., Comparative susceptibility of chickens and turkeys to avian influenza A H7N2 virus infection and protective efficacy of a commercial avian influenza H7N2 virus vaccine, Avian Dis., 48, pp. 167-176, (2004); 
Van Der Goot J.A., Koch G., De Jong M.C.M., Van Boven M., Transmission dynamics of low-and high-pathogenicity A/chicken/Pennsylvania/83 avian influenza viruses, Avian Dis., 47, pp. 939-941, (2003); 
Villarreal C., Experience in control of avian influenza in the Americas, Dev. Biol. (Basel), 130, pp. 53-60, (2007); 
Cumulative Number of Confirmed Human Cases for Avian Influenza A (H5N1) Reported to WHO [2003-2012], (2012)#FRF#
